The post Why I Can’t Stop Buying AbbVie Stock appeared first on 24/7 Wall St..
Quick Read
AbbVie (ABBV) offers compelling bull case at $208.99, with consensus buy ratings and upside potential.
Skyrizi and Rinvoq replacing Humira faster than expected, driving immunology segment 18.3% growth in Q4.
The analyst who called NVIDIA in 2010 just named his top 10 AI stocks. Get them here FREE. AbbVie (NYSE:ABBV) has attracted persistent buying inter…